Q4 2024 Management View CEO Dan Chard highlighted that 2024 was a transformative year for Medifast due to the increasing adoption of GLP-1 weight loss medications. The company is adapting to these ...

The 52-week low serves as a critical indicator of the hurdles Medifast faces in a competitive ... falling by 40.6% year-over-year to $140.2 million and a net income of $1.1 million or $0.10 ...

Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ...

Nasdaq provides NLS Volume, Previous Close, Today's High & Low, and the 52 week High & Low. The intraday chart, the last-five real-time quotes and sales data. Real-time stock quotes can be used to ...

Medifast has a 52-week low of $14.76 and a 52-week high of $52.96. The company has a quick ratio of 2.55, a current ratio of 3.11 and a debt-to-equity ratio of 0.06. The company’s 50-day simple ...

BALTIMORE (AP) — BALTIMORE (AP) — Medifast Inc. (MED) on Tuesday reported profit of $800,000 in its fourth quarter. On a per-share basis, the Baltimore-based company said it had profit of 7 cents.

Reports Q4 revenue $119M vs. $191M last year. “This past year was a pivotal year for Medifast (MED), as we continued to transform our business ...

Medifast, Inc. MED has introduced a high-protein ... OPTAVIA ASCEND is integrated into two new science-backed nutrition plans, complementing OPTAVIA's comprehensive approach to fill a critical ...

These products are featured in two new science-backed nutrition plans designed ... With its stock down 15% over the past week, it is easy to disregard Medifast (NYSE:MED). It is possible that the ...